Top Amniotic Membrane Companies

Amniotic Membrane Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.96 Billion in 2025 to USD 18.37 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026–2033).

The amniotic membrane market also has a high level of amniotic membrane industry concentration with few key market players. Rising applications in wound healing, ophthalmology and regenerative medicine are projected to drive the market. Regulatory frameworks also aid innovation by providing stringent standards, encouraging companies to derive new and innovative treatment options. Of course, regulations can inflate the cost and time of development, but they are imperative as they ultimately signal market credibility and growth. The dynamic nature of the amniotic membrane industry, along with a propensity for research and development, lead to increased mergers & acquisitions placed in the sector. M&A transactions allow companies to innovate their products and offer solutions that are more suited to the new era of healthcare professionals. 'MiMedx Group, Inc. (USA)', 'Integra LifeSciences Holdings Corporation. (USA) ', 'Organogenesis Holdings Inc. (USA) ', 'Smith & Nephew plc. (UK) ', 'BioTissue Holdings Inc. (USA) ', 'Amnio Technology, LLC. (USA) ', 'Applied Biologics LLC. (USA) ', 'Celularity Inc. (USA) ', 'Corza Health, Inc. (USA) ', 'Skye Biologics, Inc. (USA) ', 'Human Regenerative Technologies, LLC. (USA) ', 'Katena Products Inc. (USA) ', 'TissueTech Inc. (BioTissue) (USA) ', 'Amniox Medical Inc. (USA) ', 'Laboratoire CCD. (France) ', 'VIVEX Biologics Inc. (USA) ', 'Merakris Therapeutics. (USA) ', 'Thea Pharma (France) ', 'Allosure, Inc. (USA)', 'Xtant Medical Holdings Inc. (USA)'

Growing cases of workforce with extreme injuries while performing fieldwork is escalating the need for rapid and effective healing therapies. Amongst children and young adults, road accidents are the commonest causes of traumatic injuries. Road safety is being breached and traffic congestion is on the rise, pushing accident rates higher in countries around the world. Hence, in turn increasing the number of accident cases and trauma is supporting amniotic membrane market revenue.  

Improving Healthcare Policies in Emerging Economies: Emerging nations like China, India, South Korea and Brazil, Mexico provide a potential growth opportunities due to less regulatory hurdles, improved healthcare infrastructure, ever-growing patient population and increasing healthcare expenditure. In addition, governance in the Asia Pacific remain much far more flexible as well as pro-business than developed nations around the world. Together with growing global competitiveness in established markets, this has attracted major players focused on emerging economies.

In 2023, the overall global Amniotic Membrane Market was dominated by North America and generated the largest amniotic membrane market share across all regions. The growth in this region is primarily due to established healthcare infrastructure and leading players operating in the field. High availability of regenerative medicine and rising adoption of novel technologies is a major driver to bolster the amniotic membrane market growth across this region. Several key developments that support the use of amniotic membranes for ocular and wound healing treatments have helped continue this development. Moreover, supportive regulatory frameworks and ongoing investments into research & development bolster the market outlook for this segment over the forecast period.